Is Ventfort FDA approved?
No. This profile records Ventfort as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE ARTERY RESTORER
A-16 Vascular Bioregulator Peptide
Ventfort is a bioregulator peptide derived from blood vessel tissue that helps restore the health of your arteries and veins. It works by enhancing nitric oxide production for better blood flow, promoting arterial elasticity, and reducing vascular inflammation. Ideal for people with cardiovascular risk factors or age-related circulation decline.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
May 8, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Ventfort as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 20 mg orally each morning.
Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Upregulates eNOS for improved vasodilation and blood flow
Restores smooth muscle and extracellular matrix via TGF-β/SMAD signaling
Downregulates NF-κB and adhesion molecules (VCAM-1, ICAM-1)
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.